|
Market Closed -
OTC Markets
13:57:04 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 8.670 USD | -2.03% |
|
-2.03% | -45.81% |
| 09-16 | Zealand Pharma A/S Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 11:30 AM | |
| 09-15 | Elvinix licenses diabetes portfolio from Zealand Pharma | FW |
Chart: Technical Analysis
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| ZEAL | Delayed | |
CBOE
| ZEALc | Real-time | |
|
Tradegate
| 22Z | Real-time | |
|
OTC Markets
| ZLDPF | Delayed | |
|
Xetra
| 22Z | End-of-day quote | |
|
Boerse Muenchen
| 22Z | Real-time | |
|
London S.E.
| 0NZU | Delayed | |
|
Deutsche Boerse AG
| 22Z | Delayed | |
|
CBOE
| 0NZU | Real-time | |
|
Börse Stuttgart
| 22Z | Delayed | |
|
Wiener Boerse
| ZEAL | End-of-day quote | |
OTC Markets
| ZLDPY | Delayed | |
|
Deutsche Boerse AG
| 22Z1 | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ZEAL Stock
- ZLDPY Stock
- Charts Zealand Pharma A/S
Select your edition
All financial news and data tailored to specific country editions
